These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 24324033)
21. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment. Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748 [TBL] [Abstract][Full Text] [Related]
22. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201 [TBL] [Abstract][Full Text] [Related]
23. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma. Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195 [TBL] [Abstract][Full Text] [Related]
24. miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop. Zhang Y; Dai J; Deng H; Wan H; Liu M; Wang J; Li S; Li X; Tang H Br J Cancer; 2015 Jan; 112(2):365-74. PubMed ID: 25422913 [TBL] [Abstract][Full Text] [Related]
25. The Antiproliferative Activity of Oxypeucedanin via Induction of G Park SH; Hong JY; Park HJ; Lee SK Molecules; 2020 Jan; 25(3):. PubMed ID: 31979361 [TBL] [Abstract][Full Text] [Related]
26. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739 [TBL] [Abstract][Full Text] [Related]
28. Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis. Sharula ; Wu Z Anticancer Agents Med Chem; 2017; 17(7):941-947. PubMed ID: 28356025 [TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma and chemotherapy: the role of p53. Brito AF; Abrantes AM; Pinto-Costa C; Gomes AR; Mamede AC; Casalta-Lopes J; Gonçalves AC; Sarmento-Ribeiro AB; Tralhão JG; Botelho MF Chemotherapy; 2012; 58(5):381-6. PubMed ID: 23257706 [TBL] [Abstract][Full Text] [Related]
30. Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein. Dong C; Zhao B; Long F; Liu Y; Liu Z; Li S; Yang X; Sun D; Wang H; Liu Q; Liang R; Li Y; Gao Z; Shao S; Miao QR; Wang L Oncotarget; 2016 Feb; 7(8):8850-65. PubMed ID: 26840457 [TBL] [Abstract][Full Text] [Related]
31. Mir-509-5p joins the Mdm2/p53 feedback loop and regulates cancer cell growth. Ren ZJ; Nong XY; Lv YR; Sun HH; An PP; Wang F; Li X; Liu M; Tang H Cell Death Dis; 2014 Aug; 5(8):e1387. PubMed ID: 25144722 [TBL] [Abstract][Full Text] [Related]
32. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells. Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051 [TBL] [Abstract][Full Text] [Related]
33. MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53. Wang W; Cheng JW; Qin JJ; Hu B; Li X; Nijampatnam B; Velu SE; Fan J; Yang XR; Zhang R Cancer Lett; 2019 Sep; 459():156-167. PubMed ID: 31181320 [TBL] [Abstract][Full Text] [Related]
34. Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma. Shen H; Li W; Tian Y; Xu P; Wang H; Zhang J; Li Y J Cell Biochem; 2015 Aug; 116(8):1563-73. PubMed ID: 25649327 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Xu Y; Xia F; Ma L; Shan J; Shen J; Yang Z; Liu J; Cui Y; Bian X; Bie P; Qian C Cancer Lett; 2011 Nov; 310(2):160-9. PubMed ID: 21802841 [TBL] [Abstract][Full Text] [Related]
37. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Zhu Q; Wang Z; Hu Y; Li J; Li X; Zhou L; Huang Y Oncol Rep; 2012 May; 27(5):1660-8. PubMed ID: 22322403 [TBL] [Abstract][Full Text] [Related]
38. TP53/miR-129/MDM2/4/TP53 feedback loop modulates cell proliferation and apoptosis in retinoblastoma. Yao X; Shen H; Peng Q; Yu J Cell Cycle; 2021; 20(5-6):603-615. PubMed ID: 33678118 [TBL] [Abstract][Full Text] [Related]
39. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related]
40. [Effects of plumbagin on proliferation and apoptosis of human hepatocellular carcinoma cells based on CKB/p53 signaling pathway]. Zhou FL; Yuan B; Ye YX; Deng SY; Ma J; Liu H; Ma YZ; Wei YF Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2345-2354. PubMed ID: 38812135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]